Literature DB >> 30857489

Preliminary efficacy and mediators of interpersonal psychotherapy for reducing posttraumatic stress symptoms in an incarcerated population.

Julia W Felton1, Maji Hailemariam1, Fallon Richie1, Madhavi K Reddy2, Sophia Edukere2, Caron Zlotnick3,4, Jennifer E Johnson1.   

Abstract

AbstractObjective: Incarcerated individuals have high rates of trauma exposure. IPT reduces posttraumatic stress disorder (PTSD) symptoms in non-incarcerated adults, but has not been examined in prison populations. Moreover, little is known about the mechanisms through which IPT reduces PTSD symptoms. The current study investigated the direct and indirect effects of IPT on PTSD symptoms. We hypothesized that IPT would decrease PTSD symptoms by enhancing social support and decreasing loneliness (theorized IPT mechanisms). Method: A sub-sample of trauma-exposed participants (n = 168) were drawn from a larger randomized trial (n = 181) of IPT for major depressive disorder among prisoners. We examined a series of mediation models using non-parametric bootstrapping procedures to evaluate the indirect effect of IPT on PTSD symptoms.
Results: Contrary to hypotheses, the relation between IPT and PTSD symptoms was significantly mediated through improvements in hopelessness and depressive symptoms (mechanisms of cognitive behavioral interventions), rather than through social support and loneliness. Increased social support and decreased loneliness were associated with decreased PTSD symptoms, but IPT did not predict changes in social support or loneliness. Conclusions: IPT may reduce PTSD symptoms in depressed prisoners by reducing hopelessness and depression. (ClinicalTrials.gov number NCT01685294).

Entities:  

Keywords:  PTSD; Trauma; interpersonal psychotherapy; intervention; prison

Year:  2019        PMID: 30857489      PMCID: PMC6739190          DOI: 10.1080/10503307.2019.1587192

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  63 in total

1.  Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder.

Authors:  Elina A Stefanovics; Robert A Rosenheck; Karen M Jones; Grant Huang; John H Krystal
Journal:  Psychiatr Q       Date:  2018-03

Review 2.  Mediators and mechanisms of change in psychotherapy research.

Authors:  Alan E Kazdin
Journal:  Annu Rev Clin Psychol       Date:  2007       Impact factor: 18.561

3.  Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models.

Authors:  Kristopher J Preacher; Andrew F Hayes
Journal:  Behav Res Methods       Date:  2008-08

4.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

Review 5.  Public health and the epidemic of incarceration.

Authors:  Dora M Dumont; Brad Brockmann; Samuel Dickman; Nicole Alexander; Josiah D Rich
Journal:  Annu Rev Public Health       Date:  2012-01-03       Impact factor: 21.981

6.  A Pilot Study of Interpersonal Psychotherapy for PTSD in Women Veterans.

Authors:  Janice L Krupnick; Elizabeth Melnikoff; Matthew Reinhard
Journal:  Psychiatry       Date:  2016       Impact factor: 2.458

7.  Women with co-occurring substance use and mental disorders (COD) in the criminal justice system: a research review.

Authors:  JoAnn Y Sacks
Journal:  Behav Sci Law       Date:  2004

8.  Emotion processing in the criminal psychopath: the role of attention in emotion-facilitated memory.

Authors:  Samantha J Glass; Joseph P Newman
Journal:  J Abnorm Psychol       Date:  2009-02

9.  A pilot study of group interpersonal psychotherapy for depression in substance-abusing female prisoners.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Subst Abuse Treat       Date:  2007-07-13

10.  Interpersonal psychotherapy versus treatment as usual for PTSD and depression among Sichuan earthquake survivors: a randomized clinical trial.

Authors:  Rui Fang Jiang; Hui Qi Tong; Kevin L Delucchi; Thomas C Neylan; Qijia Shi; Susan M Meffert
Journal:  Confl Health       Date:  2014-09-04       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.